Clinical Trial

An Exosomal miRNA-based Liquid Biopsy for ICC Detection

Study acronym: LUMIC
Completed
View on ClinicalTrials.gov →
Summary
Intrahepatic cholangiocarcinoma (ICC) is a malignant liver tumor with poor prognosis and limited curative treatment options. Early and accurate detection remains an unmet clinical need. The LUMIC study aims to develop a non-invasive liquid biopsy platform based on both exosomal microRNAs (exo-miRNAs) to detect intrahepatic cholangiocarcinoma with high sensitivity and specificity.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-11-04; most recent amendment 2026-03-11.
Status change: Recruiting → Completed 2026-03-11
Trial Details
NCT Number NCT07225452
Lead Sponsor City of Hope Medical Center
Conditions Intrahepatic Cholangiocarcinoma (Icc)
Enrollment 535 participants
Start Date 2024-06-21
Primary Completion 2026-01-05 (estimated)
Study Completion 2026-02-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-13